Nuzenio

Companion Diagnostic Approval

Companion Diagnostic Approval news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 7 publisher sources 100/100 entity strength

Latest news

CellCarta adds Tempus to companion diagnostic commercialisation network - Manufacturing ChemistManufacturing Chemist · Fri, 07 Aug 2026 11:00:39 GMTEU Clears PD-L1 IHC 22C3 pharmDx as Companion Diagnostic for Pembrolizumab in Ovarian Cancer - onclive.comonclive.com · Thu, 06 Aug 2026 13:13:30 GMTLabcorp Launches FDA-Approved IHC Companion Diagnostic for Prostate Cancer - Clinical Lab ProductsClinical Lab Products · Wed, 05 Aug 2026 20:52:25 GMTSOPHiA GENETICS and AstraZeneca Collaborate to Develop Oncology Companion Diagnostics - Clinical Lab ProductsClinical Lab Products · Wed, 05 Aug 2026 20:52:25 GMTSignatera Is Submitted to Japan's PMDA for Companion Diagnostic Approval in MIBC - onclive.comonclive.com · Wed, 05 Aug 2026 15:09:02 GMTNatera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 10:00:00 GMTAfter U.S. approval, Natera submits bladder cancer test in Japan - Stock TitanStock Titan · Wed, 05 Aug 2026 10:00:00 GMTLabcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer - PR NewswirePR Newswire · Tue, 04 Aug 2026 11:00:00 GMT

Timeline

Fri, 07 Aug 2026 11:00:39 GMTCellCarta adds Tempus to companion diagnostic commercialisation network - Manufacturing Chemist
Thu, 06 Aug 2026 13:13:30 GMTEU Clears PD-L1 IHC 22C3 pharmDx as Companion Diagnostic for Pembrolizumab in Ovarian Cancer - onclive.com
Wed, 05 Aug 2026 20:52:25 GMTLabcorp Launches FDA-Approved IHC Companion Diagnostic for Prostate Cancer - Clinical Lab Products
Wed, 05 Aug 2026 20:52:25 GMTSOPHiA GENETICS and AstraZeneca Collaborate to Develop Oncology Companion Diagnostics - Clinical Lab Products
Wed, 05 Aug 2026 15:09:02 GMTSignatera Is Submitted to Japan's PMDA for Companion Diagnostic Approval in MIBC - onclive.com
Wed, 05 Aug 2026 10:00:00 GMTNatera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer - Yahoo Finance

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Companion Diagnostic Approval.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.